| Primary |
| Actinic Keratosis |
20.9% |
| Genital Herpes |
10.5% |
| Basal Cell Carcinoma |
9.3% |
| Product Used For Unknown Indication |
8.7% |
| B-cell Unclassifiable Lymphoma Low Grade |
8.1% |
| Precancerous Skin Lesion |
7.6% |
| Anogenital Warts |
5.8% |
| Hypertension |
5.8% |
| Hormone Replacement Therapy |
3.5% |
| Skin Papilloma |
3.5% |
| Atrial Fibrillation |
2.3% |
| Haemangioma Of Skin |
2.3% |
| Blood Pressure |
1.7% |
| Blood Pressure Abnormal |
1.7% |
| Hyperkeratosis |
1.7% |
| Squamous Cell Carcinoma |
1.7% |
| Arthralgia |
1.2% |
| Blood Cholesterol |
1.2% |
| Cheilitis |
1.2% |
| Headache |
1.2% |
|
| Rash |
12.8% |
| Application Site Pain |
6.4% |
| Drug Ineffective |
6.4% |
| Pain |
6.4% |
| Skin Exfoliation |
6.4% |
| Application Site Pruritus |
4.3% |
| Dizziness |
4.3% |
| Drug Ineffective For Unapproved Indication |
4.3% |
| Haemodialysis |
4.3% |
| Hypotension |
4.3% |
| Off Label Use |
4.3% |
| Overdose |
4.3% |
| Pneumonia |
4.3% |
| Pulmonary Embolism |
4.3% |
| Pyrexia |
4.3% |
| Skin Reaction |
4.3% |
| Treatment Noncompliance |
4.3% |
| Vomiting |
4.3% |
| Wound Secretion |
4.3% |
| Altered State Of Consciousness |
2.1% |
|
| Secondary |
| Cutaneous Sarcoidosis |
17.5% |
| Precancerous Skin Lesion |
14.2% |
| Hypertension |
11.7% |
| Hyperkeratosis |
9.2% |
| Basal Cell Carcinoma |
8.3% |
| Product Used For Unknown Indication |
6.7% |
| Hormone Replacement Therapy |
5.0% |
| Actinic Keratosis |
4.2% |
| Headache |
3.3% |
| Anogenital Warts |
2.5% |
| Pain |
2.5% |
| Psoriasis |
2.5% |
| Renal Transplant |
2.5% |
| Cheilitis |
1.7% |
| Crohn's Disease |
1.7% |
| Psoriatic Arthropathy |
1.7% |
| Skin Cancer |
1.7% |
| Squamous Cell Carcinoma |
1.7% |
| Atrial Fibrillation |
0.8% |
| Bowen's Disease |
0.8% |
|
| Application Site Inflammation |
17.9% |
| Wrong Technique In Drug Usage Process |
10.7% |
| Drug Ineffective |
7.1% |
| Pancytopenia |
7.1% |
| Application Site Pruritus |
3.6% |
| Application Site Scar |
3.6% |
| Application Site Ulcer |
3.6% |
| Basal Cell Carcinoma |
3.6% |
| Hypotension |
3.6% |
| Infected Skin Ulcer |
3.6% |
| Myocardial Infarction |
3.6% |
| Osteonecrosis |
3.6% |
| Papilloma Viral Infection |
3.6% |
| Pemphigus |
3.6% |
| Sarcoidosis |
3.6% |
| Skin Exfoliation |
3.6% |
| Skin Lesion |
3.6% |
| Skin Reaction |
3.6% |
| Skin Ulcer |
3.6% |
| Social Problem |
3.6% |
|
| Concomitant |
| Hiv Infection |
24.3% |
| Behcet's Syndrome |
14.8% |
| Drug Use For Unknown Indication |
14.8% |
| Product Used For Unknown Indication |
9.2% |
| Hypertension |
4.6% |
| Anogenital Warts |
4.2% |
| Immunosuppression |
3.9% |
| Prophylaxis |
3.5% |
| Actinic Keratosis |
2.1% |
| Asthma |
2.1% |
| Neuropathy Peripheral |
2.1% |
| Affective Disorder |
1.8% |
| Epilepsy |
1.8% |
| Hypertonic Bladder |
1.8% |
| Schizoaffective Disorder |
1.8% |
| Tremor |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.4% |
| Constipation |
1.4% |
| Hepatitis C |
1.4% |
| Multiple Sclerosis |
1.4% |
|
| Immune Reconstitution Inflammatory Syndrome |
6.7% |
| Muscle Rupture |
6.7% |
| Osteomyelitis |
6.7% |
| Platelet Count Decreased |
6.7% |
| Pyrexia |
6.7% |
| Salivary Gland Pain |
6.7% |
| Sepsis |
6.7% |
| Squamous Cell Carcinoma Of Skin |
6.7% |
| Trichostasis Spinulosa |
6.7% |
| Vomiting |
6.7% |
| Angina Pectoris |
3.3% |
| Anogenital Warts |
3.3% |
| Application Site Scab |
3.3% |
| Basal Cell Carcinoma |
3.3% |
| Blood Testosterone Increased |
3.3% |
| Blood Urea Increased |
3.3% |
| Brain Stem Haemorrhage |
3.3% |
| Breast Cancer |
3.3% |
| C-reactive Protein Increased |
3.3% |
| Cerebellar Atrophy |
3.3% |
|
| Interacting |
| Atrial Fibrillation |
25.0% |
| Basal Cell Carcinoma |
25.0% |
| Crohn's Disease |
25.0% |
| Drug Use For Unknown Indication |
25.0% |
|
| International Normalised Ratio Increased |
33.3% |
| Local Reaction |
33.3% |
| Pancytopenia |
33.3% |
|
